Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 75
- +42 vs. Q3 2024
- Shares held
- 38.5M
- +20.0M (+108.2%) vs. Q3 2024
- Total value
- $158.5M
- +$112.5M (+244.4%) vs. Q3 2024
- New holders
- 45
- 19 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 6,293,282 | $25.9M | 0.88% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,566,338 | $14.7M | 0.20% | +3,566,338 | New |
| Vanguard Group Inc | 2,894,639 | $11.9M | 0.00% | +1,329,152+84.9% | Added |
| Sphera Funds Management Ltd. | 2,551,619 | $10.5M | 1.94% | +1,254,298+96.7% | Added |
| First Light Asset Management, LLC | 2,328,768 | $9.59M | 0.92% | +2,328,768 | New |
| Blue Owl Capital Holdings LP | 1,959,912 | $8.07M | 1.91% | +1,959,912 | New |
| Woodline Partners LP | 1,671,822 | $6.89M | 0.05% | +828,930+98.3% | Added |
| Schonfeld Strategic Advisors LLC | 1,515,750 | $6.24M | 0.04% | +15,750+1.1% | Added |
| Ensign Peak Advisors, Inc | 1,264,919 | $5.21M | 0.01% | +821,918+185.5% | Added |
| Frazier Life Sciences Management, L.P. | 1,176,735 | $4.85M | 0.20% | +1,176,735 | New |
| Nantahala Capital Management, LLC | 1,147,946 | $4.73M | 0.33% | +547,946+91.3% | Added |
| Ikarian Capital, LLC | 1,126,637 | $4.64M | 1.33% | +1,126,637 | New |
| AWM Investment Company, Inc. | 1,100,473 | $4.53M | 0.55% | +1,100,473 | New |
| Point72 Asset Management, L.P. | 1,095,000 | $4.51M | 0.01% | +1,095,000 | New |
| Alyeska Investment Group, L.P. | 933,475 | $3.85M | 0.01% | +433,475+86.7% | Added |
| Sanofi | 814,980 | $3.36M | 1.93% | +814,980 | New |
| Zimmer Partners, LP | 750,000 | $3.09M | 0.05% | −684,727−47.7% | Reduced |
| Geode Capital Management, LLC | 663,101 | $2.73M | 0.00% | +285,043+75.4% | Added |
| BlackRock, Inc. | 617,624 | $2.54M | 0.00% | +401,756+186.1% | Added |
| Boothbay Fund Management, LLC | 341,923 | $1.41M | 0.04% | +341,923 | New |
| Velan Capital Investment Management LP | 323,973 | $1.33M | 1.15% | +323,973 | New |
| UBS Group AG | 318,581 | $1.31M | 0.00% | +318,577+7,964,425.0% | Added |
| CM Management, LLC | 275,000 | $1.13M | 1.01% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 269,025 | $1.11M | 0.00% | +249,155+1,253.9% | Added |
| Exome Asset Management LLC | 256,373 | $1.06M | 0.79% | +256,373 | New |
| Acuta Capital Partners, LLC | 235,750 | $971.3K | 0.98% | +235,750 | New |
| CWM Advisors, LLC | 194,688 | $802.1K | 0.09% | +194,688 | New |
| Citadel Advisors LLC | 189,870 | $782.3K | 0.00% | +189,870 | New |
| State Street Corp | 187,001 | $770.4K | 0.00% | +25,509+15.8% | Added |
| Morgan Stanley | 174,506 | $719.0K | 0.00% | +91,035+109.1% | Added |
| 683 Capital Management, LLC | 154,960 | $638.4K | 0.06% | +154,960 | New |
| Renaissance Technologies LLC | 147,173 | $606.4K | 0.00% | +11,300+8.3% | Added |
| Goldman Sachs Group Inc | 144,845 | $596.8K | 0.00% | +144,845 | New |
| Northern Trust Corp | 126,885 | $522.8K | 0.00% | +34,992+38.1% | Added |
| Jane Street Group, LLC | 122,275 | $503.8K | 0.00% | +122,275 | New |
| Qube Research & Technologies Ltd | 122,141 | $503.2K | 0.00% | +122,141 | New |
| Millennium Management LLC | 118,861 | $489.7K | 0.00% | +118,861 | New |
| EAM Investors, LLC | 109,555 | $451.4K | 0.06% | +109,555 | New |
| Allostery Investments LP | 100,000 | $412.0K | 0.81% | +100,000 | New |
| Bank of America Corp | 95,142 | $392.0K | 0.00% | +88,326+1,295.9% | Added |
| Marshall Wace, LLP | 80,431 | $331.4K | 0.00% | +80,431 | New |
| Diadema Partners LP | 75,794 | $312.3K | 0.35% | +75,794 | New |
| Prelude Capital Management, LLC | 74,576 | $307.3K | 0.03% | +74,576 | New |
| Barclays PLC | 70,000 | $288.4K | 0.00% | +70,000 | New |
| Citigroup Inc | 66,900 | $275.6K | 0.00% | +66,900 | New |
| Omers Administration Corp | 62,800 | $258.7K | 0.00% | +62,800 | New |
| Jmac Enterprises LLC | 58,041 | $239.1K | 0.04% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 51,849 | $214.0K | 0.01% | 00.0% | Unchanged |
| Alps Advisors Inc | 48,310 | $199.0K | 0.00% | +48,310 | New |
| Pathstone Holdings, LLC | 39,814 | $164.0K | 0.00% | +26,785+205.6% | Added |
| Bridgeway Capital Management, LLC | 33,400 | $137.6K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 32,623 | $134.4K | 0.00% | +32,623 | New |
| Marco Investment Management LLC | 30,344 | $125.0K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 29,987 | $123.5K | 0.00% | +15,000+100.1% | Added |
| Kera Capital Partners, Inc. | 25,770 | $106.2K | 0.03% | +25,770 | New |
| Cubist Systematic Strategies, LLC | 24,568 | $101.2K | 0.00% | +24,568 | New |
| Dimensional Fund Advisors LP | 23,033 | $94.9K | 0.00% | −11,190−32.7% | Reduced |
| Jefferies Financial Group Inc. | 22,000 | $90.6K | 0.00% | +22,000 | New |
| Virtu Financial LLC | 20,016 | $82.0K | 0.00% | +20,016 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 18,379 | $75.7K | 0.02% | +18,379 | New |
| Mercer Global Advisors Inc | 16,726 | $68.9K | 0.00% | 00.0% | Unchanged |
| Persistent Asset Partners Ltd | 14,855 | $67.1K | 0.06% | +14,855 | New |
| ADAR1 Capital Management, LLC | 16,000 | $65.9K | 0.01% | +16,000 | New |
| Alpine Global Management, LLC | 13,471 | $55.5K | 0.02% | +13,471 | New |
| Clarity Capital Partners LLC | 11,500 | $47.4K | 0.02% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 11,303 | $46.6K | 0.00% | +11,303 | New |
| Simplex Trading, LLC | 10,437 | $43.0K | 0.00% | +10,437 | New |
| Tower Research Capital LLC (TRC) | 7,944 | $32.7K | 0.00% | +6,412+418.5% | Added |
| Point72 (DIFC) Ltd | 4,462 | $18.4K | 0.00% | +4,462 | New |
| Addison Advisors LLC | 1,300 | $5.36K | 0.00% | +1,300 | New |
| Jones Financial Companies LLLP | 625 | $2.58K | 0.00% | +625 | New |
| Group One Trading, L.P. | 591 | $2.44K | 0.00% | +591 | New |
| Insight Financial Services | 100 | $412 | 0.00% | +100 | New |
| SBI Securities Co., Ltd. | 43 | $177 | 0.00% | +43 | New |
| FMR LLC | 17 | $70 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,364,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,027−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −97−100.0% | Sold out |